AI
ACLX

Allostery Investments’s Arcellx ACLX Stock Holding History

Allostery Investments’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,000
Closed -$65.8K – 2
2025
Q2 		$65.8K Sell
1,000
-43,000
-98% -$2.68M 0.84% 19
2025
Q1 		$2.89M Buy
44,000
+9,000
+26% +$610K 4.16% 10
2024
Q4 		$2.68M Buy
+35,000
New +$3.02M 2.8% 12

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Allostery Investments's ACLX Position: Q3 2025 in Review

Allostery Investments sold out of Arcellx (ACLX) in Q3 2025, closing a stake of 1,000 shares — an estimated $65.8K sold.

Allostery Investments first reported a position in ACLX in Q4 2024 and held it in 3 quarters. The position peaked at $2.89M in Q1 2025. 209 funds tracked by Wall St. Rank hold ACLX as of Q3 2025.

  • Allostery Investments reported no remaining Arcellx position as of Q3 2025 after selling out during the quarter.
  • Allostery Investments sold 1,000 Arcellx shares in Q3 2025, an estimated $65.8K.
  • Allostery Investments first reported a position in Arcellx in Q4 2024 and held it in 3 quarters.
  • Allostery Investments's Arcellx position peaked at $2.89M in Q1 2025.
  • 209 funds tracked by Wall St. Rank held Arcellx as of Q3 2025.

Based on Allostery Investments's 13F filing for Q3 2025.